Inicio
Detalle del título uniforme
European Neurological Review
Tipo de obra :
Autre
Naturaleza de la obra :
Oeuvre
|
Documentos disponibles con este título uniforme (1)
Clasificado(s) por (Año de edición descendente) Refinar búsqueda
Título : Treatment of aggressive pituitary adenomas and carcinomas – an overview Tipo de documento : documento electrónico Autores : Luis Vicente Syro Moreno, Fecha de publicación : 2012 Títulos uniformes : European Neurological Review Idioma : Inglés (eng) Palabras clave : Pituitary adenoma pituitary carcinoma O6-methylguanine-DNA methyltransferase (MGMT) temozolomide everolimus bevacizumab Resumen : Most pituitary tumours are non-invasive, benign adenomas that remain confined to the sella turcica. Some of them recur, have a rapid growth rate, and invade surrounding tissues. These adenomas, considered aggressive pituitary tumours, are difficult to manage and present problems due to incomplete resection. A pituitary carcinoma is diagnosed when craniospinal and/or systemic metastases are documented. Treatment options for pituitary adenomas are surgery, radiation and drugs. Recent publications report the efficacy of temozolomide in the treatment of aggressive pituitary adenomas and carcinomas. Indications for, results with, and side effects of temozolomide therapy in aggressive pituitary tumours and pituitary carcinomas are reviewed here. Alternative treatment options for resistant or recurrent pituitary tumours are also discussed. Mención de responsabilidad : Luis V Syro, Leon D Ortiz, Fabio Rotondo, Humberto Uribe, Luis C Penagos, Eva Horvath, Kalman Kovacs Referencia : European Neurological Review. 2012;7(3):178–80. DOI (Digital Object Identifier) : 10.17925/ENR.2012.07.03.178 En línea : https://touchneurology.com/treatment-of-aggressive-pituitary-adenomas-and-carcin [...] Enlace permanente : https://hospitalpablotobon.cloudbiteca.com/pmb/opac_css/index.php?lvl=notice_display&id=3630 Treatment of aggressive pituitary adenomas and carcinomas – an overview [documento electrónico] / Luis Vicente Syro Moreno, . - 2012.
Obra : European Neurological Review
Idioma : Inglés (eng)
Palabras clave : Pituitary adenoma pituitary carcinoma O6-methylguanine-DNA methyltransferase (MGMT) temozolomide everolimus bevacizumab Resumen : Most pituitary tumours are non-invasive, benign adenomas that remain confined to the sella turcica. Some of them recur, have a rapid growth rate, and invade surrounding tissues. These adenomas, considered aggressive pituitary tumours, are difficult to manage and present problems due to incomplete resection. A pituitary carcinoma is diagnosed when craniospinal and/or systemic metastases are documented. Treatment options for pituitary adenomas are surgery, radiation and drugs. Recent publications report the efficacy of temozolomide in the treatment of aggressive pituitary adenomas and carcinomas. Indications for, results with, and side effects of temozolomide therapy in aggressive pituitary tumours and pituitary carcinomas are reviewed here. Alternative treatment options for resistant or recurrent pituitary tumours are also discussed. Mención de responsabilidad : Luis V Syro, Leon D Ortiz, Fabio Rotondo, Humberto Uribe, Luis C Penagos, Eva Horvath, Kalman Kovacs Referencia : European Neurological Review. 2012;7(3):178–80. DOI (Digital Object Identifier) : 10.17925/ENR.2012.07.03.178 En línea : https://touchneurology.com/treatment-of-aggressive-pituitary-adenomas-and-carcin [...] Enlace permanente : https://hospitalpablotobon.cloudbiteca.com/pmb/opac_css/index.php?lvl=notice_display&id=3630 Reserva
Reservar este documentoEjemplares(1)
Código de barras Número de Ubicación Tipo de medio Ubicación Sección Estado DD000200 AC-2012-040 Archivo digital Producción Científica Artículos científicos Disponible